Gaithersburg, Md.– March 17, 2015 — VLP Therapeutics, LLC. (“VLP”), a Gaithersburg-based biotechnology company focusing on the research and development of therapeutic and preventative vaccines and next generation antibody agents based upon a novel and proprietary vaccine technology, today announced that it has entered into a collaboration with Mitsubishi Heavy Industries to facilitate VLP’s on-going research and development of virus like particles.
“I am very pleased to partner with the global company like Mitsubishi Heavy Industries. Mitsubishi’s mission to support the next generation of people by creating an innovative technology matches VLP’s mission to solve the 21st century global health problems through our innovative and revolutionary i-alpha VLP technology. The collaboration will facilitate our on-going effort in developing an innovative technology” said Dr. Wataru Akahata, Ph.D., Co-Founder and Chief Executive Officer of VLP.
About VLP Therapeutics
VLP was established in 2012 by a group of seasoned entrepreneurs based upon a novel, proprietary vaccine technology discovered by its co-founder Dr. Akahata. Its vision is to combat the 21st century global public health problems through revolutionary i-alpha VLP Technology, and the mission is to develop innovative medical treatment which transforms traditional vaccine and targeted antibody therapies to address global unmet medical needs. VLP is currently developing preventative and therapeutic vaccines as well as next generation of targeted antibody agents to treat cancer, infectious diseases, auto-immune diseases and neurological diseases.
About the Mitsubishi Heavy Industries, Ltd.
Mitsubishi Heavy Industries is a global company with vision to provide the next generation with an assured future of comfortable lives and happiness through technologies that excite people and their passion for manufacturing. To achieve this aim, Mitsubishi Heavy Industries seek to provide further value by improving the technologies they have fostered and using new ideas and concepts to integrate our diverse technologies. From a global perspective, they work to solve the problems facing humankind and to realize everyone’s dreams.